Research and governmental initiatives around Grid technology for medical and health care purposes have been an important element of Grid usage from the early prototypes of finding cures for diseases using spare cycles on PCs. There are now far more ambitious programmes in place to explore the opportunity for using Grids as the backbone for electronic health records and new medical infrastructures. Money from both the European Union and the United States government has been pointed in this direction, and this report looks at the success and future developments in such initiatives.
This report analyses the status of Grid activity at health care companies and assesses when and how they could move beyond initial high performance computing applications. It highlights the leading examples of Grid usage across this sector, and looks at the scope of activities in areas such as virtualization and service-oriented architecture (SOA) that are under way.
Early-adopter case studies include companies and projects such as Acxiom, Agfa, Archimedes, Bristol-Myers Squibb, caBIG, GlaxoSmithKline, HealthGrid.US Alliance, Johnson & Johnson, MammoGrid, SHARE and WISDOM. The report on Grid computing adoption in the health care market is the fifteenth Grid adoption report issued by the Grid Adoption Research Service of The 451 Group.
The 451 Group is an independent technology industry analyst company focused on the business of enterprise IT innovation. The company's analysts provide critical and timely insight into the market and competitive dynamics of innovation in emerging technology segments. Clients of the company - at vendor, investor, service-provider and end-user organisations - rely on 451 insight to support both strategic and tactical decision-making for competitive advantage.
The 451 Group is headquartered in New York, with offices in key locations, including San Francisco, London and Boston. For additional information on the report about Grid computing adoption in the health care market, you can visit the website of The 451 Group.